A Harris, L Kagemann, R Ehrlich, Y Ehrlich, … - British Journal of Ophthalmology, 2008 - bjo.bmj.com Nonarteritic anterior ischaemic optic neuropathy (NAION) has been reported in
some patients receiving sildenafil.20 NAION typically affects middle-aged and
older individuals, with an annual incidence of 10.2 per 100 000 individuals ... Cited by 3 - Related articles - BL Direct - All 8 versions
[CITATION] The phosphodiesterase 5 inhibitor sildenafil has no effect on cerebral blood flow velocity, …
- ►upenn.edu [PDF] TI Metelitsina, JE Grunwald, JC DuPont, G … - Experimental eye research, 2005 - Elsevier Double-blinded, randomized, placebo-controlled, crossover study. Fifteen male
AMD patients received a dose of 100 mg of sildenafil or matching placebo on two
separate days. Laser Doppler flowmetry was performed to assess relative ... Cited by 11 - Related articles - All 5 versions
J Stehlik, MA Movsesian - Journal of cardiac failure, 2009 - Elsevier In 3 patients with heart failure, pulmonary hypertension and low systemic
arterial pressures treated with sildenafil, systemic nitrates were added to
reduce pulmonary hypertension further. Hemodynamic measurements were made ... Cited by 2 - Related articles - All 26 versions
S Faruqi, H Fathi, AH Morice - International Journal of Cardiology, 2009 - Elsevier Sitaxentan, a highly-selective endothelin receptor antagonist (ETRA) and
bosentan a non-selective ETRA are both approved for the treatment of idiopathic
pulmonary arterial hypertension (iPAH). Sildenafil is a phosphodiesterase-5 ... Cited by 2 - Related articles - All 2 versions
CA Dias-Junior, SBA Cau, AM Oliveira, MM … - Thrombosis Research, 2009 - Elsevier Hemodynamic and biochemical evaluations were performed in non-embolized dogs
treated with saline (N = 5), and in microspheres embolized dogs receiving saline
(n = 9), or nitrite (6.75 µmol/kg iv over 15 min followed by 0.28 ... Cited by 4 - Related articles - All 15 versions
K Angelis, G Konstantinos, A Anastasios, S … - Expert Opin. Pharmacother., 2009 - informahealthcare.com Objective: To investigate the impact of daily sildenafil on levels of soluble
molecular markers of endothelial function in men with erectile dysfunction.
Methods: Patients aged > 18 years with erectile dysfunction of vascular ... Cited by 2 - Related articles - All 5 versions
P Taner, A Ergin, MM Basar, E Batislam, YK … - Neuro-ophthalmology, 2005 - informahealthcare.com Objectives: In the present study, we aimed to investigate the postural changes
of systemic blood pressure, retrobulbar blood flow velocities, and intraocular
pressure as a response to sildenafil. Material and methods: A total of 28 ... Cited by 2 - Related articles - All 5 versions
R Voswinckel, F Reichenberger, B Enke, A … - Pulmonary Pharmacology & Therapeutics, 2008 - Elsevier Inhaled nitric oxide reduced pulmonary vascular resistance (PVR) to 87.3±5.1%
of baseline values, reduced mean pulmonary arterial pressure (PAP) to 89.7±3.5%
and increased cardiac output (CO) to 102.4±2.9%. Sildenafil reduced PVR to ... Cited by 2 - Related articles - All 2 versions
K Rutten, EL Van Donkelaar, L Ferrington, A … - Neuropsychopharmacology, 2009 - nature.com Phosphodiesterase (PDE) inhibitors prevent the breakdown of the second
messengers, cyclic AMP (cAMP) and cyclic GMP (cGMP), and are currently studied
as possible targets for cognitive enhancement. Earlier studies indicated ... Cited by 2 - Related articles - All 3 versions
